These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 327016)
1. Antigenic modulation of Friend virus erythroleukemic cells in vitro by serum from mice with dormant erythroleukemia. Genovesi EV; Marx PA; Wheelock EF J Exp Med; 1977 Aug; 146(2):520-34. PubMed ID: 327016 [TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Friend virus antigen-modulated erythroleukemic cells to lysis by T lymphocytes from mice with dormant Friend virus infections. Genovesi EV; Marx PA; Wheelock EF J Immunol; 1979 Mar; 122(3):795-800. PubMed ID: 312825 [TBL] [Abstract][Full Text] [Related]
3. A radiosensitive T-lymphocyte associated with resistance of DBA/2 mice harboring Friend leukemia virus-dormant infections to transplantable Friend leukemia virus-erythroleukemia cells. DiCicco LM; Truitt GA; Wheelock EF Cancer Res; 1986 Jan; 46(1):127-32. PubMed ID: 3509990 [TBL] [Abstract][Full Text] [Related]
4. Effect of serum from mice with dormant Friend leukemia viral infections on synthesis and modulation of erythroleukemia cell surface gp70. Callahan RM; Marx PA; Marum WG; Wheelock EF J Immunol; 1980 Aug; 125(2):616-22. PubMed ID: 6930443 [TBL] [Abstract][Full Text] [Related]
5. Immunotherapy of murine leukemia. IX. The requirement for the Fc portion of antibody for successful passive serum therapy of Friend leukemia virus-induced disease. Collins JJ; Sackie DM; Johnson GR Virology; 1983 Apr; 126(1):259-66. PubMed ID: 6573816 [TBL] [Abstract][Full Text] [Related]
6. In vitro growth inhibition of murine leukemia cells by antibody specific for the major envelope glycoprotein (gp71) of Friend leukemia virus. Genovesi EV; Collins JJ J Cell Physiol; 1983 Nov; 117(2):215-29. PubMed ID: 6630299 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of murine leukemia. XI. differential susceptibility of spleen cells from serum-protected mice to the in vitro immunosuppressive effects of Friend leukemia virus-infected splenocytes. Pettey CL; Collins JJ Int J Cancer; 1984 Aug; 34(2):269-76. PubMed ID: 6540757 [TBL] [Abstract][Full Text] [Related]
8. The detection of a spleen focus-forming virus neoantigen by lymphocyte-mediated cytolysis. Gillis S; Gillis AE; Smith KA J Exp Med; 1978 Jul; 148(1):18-31. PubMed ID: 78957 [TBL] [Abstract][Full Text] [Related]
9. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice. Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370 [TBL] [Abstract][Full Text] [Related]
10. Immunoglobulins in human serum reactive with murine Friend leukaemia virus. Bendinelli M; Toniolo A; Matteucci D; Celeste F; Revoltella R J Gen Virol; 1980 Feb; 46(2):311-24. PubMed ID: 6155429 [TBL] [Abstract][Full Text] [Related]
11. Use of silica to identify host mechanisms involved in suppression of established Friend virus leukemia. Wirth JJ; Levy MH; Wheelock EF J Immunol; 1976 Dec; 117(6):2124-30. PubMed ID: 186537 [TBL] [Abstract][Full Text] [Related]
12. Antibody-induced loss of Friend virus leukemia cell surface antigens occurs during progression of erythroleukemia in F1 mice. Doig D; Chesebro B J Exp Med; 1978 Nov; 148(5):1109-21. PubMed ID: 281446 [TBL] [Abstract][Full Text] [Related]
13. Friend erythroleukemia antigen. A viral antigen specified by spleen focus-forming virus and differentiation antigen controlled by the Fv-2 locus. Risser R J Exp Med; 1979 May; 149(5):1152-67. PubMed ID: 448285 [TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of murine leukemia VI. Development of immunologic memory in mice protected against Friend leukemia virus-induced disease by passive serum therapy. Genovesi EV; Livnat D; Collins JJ Leuk Res; 1982; 6(4):577-93. PubMed ID: 6958931 [TBL] [Abstract][Full Text] [Related]
16. Immunofluorescence study of thymuses of mice given Friend leukemia virus: conventional vs monoclonal antibodies. Ranucci A; Accinni L; Del Gobbo V; Titti F; Fiorucci G; Manzari V; Premrov MG; Tonietti G Microbiologica; 1985 Jan; 8(1):1-9. PubMed ID: 3883101 [TBL] [Abstract][Full Text] [Related]
17. Discussion paper: impairment of B-lymphocyte functions in concanavalin A-treated friend virus infected mice. Kateley JR; Friedman H Ann N Y Acad Sci; 1976; 276():466-78. PubMed ID: 1088387 [TBL] [Abstract][Full Text] [Related]
18. Anti-Friend virus antibody is associated with recovery from viremia and loss of viral leukemia cell-surface antigens in leukemic mice. Identification of Rfv-3 as a gene locus influencing antibody production. Doig D; Chesebro B J Exp Med; 1979 Jul; 150(1):10-9. PubMed ID: 286744 [TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocyte recognition of gp70 on Friend virus-induced erythroleukemia cell clones. Collins JK; Britt WJ; Chesebro B J Immunol; 1980 Sep; 125(3):1318-24. PubMed ID: 6967898 [No Abstract] [Full Text] [Related]
20. Spontaneous regression of Friend murine leukemia virus-induced erythroleukemia. V. Cell-mediated antivirus immunity in mice undergoing erythroleukemia regression and in leukemic mice. Johnson CS; Fouchey SP; Furmanski P J Natl Cancer Inst; 1980 Mar; 64(3):645-53. PubMed ID: 6965511 [No Abstract] [Full Text] [Related] [Next] [New Search]